Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences

Aim. The differences between metabolic syndrome (MS) with obesity with or without comorbid pathology (chronic coronary artery disease i.e. CAD) were explicated in the research. Material and Methods. 126 patients with MS were examined. MS without chronic CAD was diagnosed in 82 patients and MS wit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	R.Ya. Dutka, N.V. Chmyr
Formato:	article
Lenguaje:	EN UK
Publicado:	Danylo Halytsky Lviv National Medical University 2017
Materias:	metabolic syndrome, obesity, prolactin, thyroid-stimulating hormone Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b2531dbb6b654cf983a2155762d62d8b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b2531dbb6b654cf983a2155762d62d8b
record_format	dspace
spelling	oai:doaj.org-article:b2531dbb6b654cf983a2155762d62d8b2021-11-10T19:50:04ZDifferential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences1029-42442415-330310.25040/aml2017.03.010https://doaj.org/article/b2531dbb6b654cf983a2155762d62d8b2017-08-01T00:00:00Zhttps://amljournal.com/index.php/journal/article/view/145https://doaj.org/toc/1029-4244https://doaj.org/toc/2415-3303Aim. The differences between metabolic syndrome (MS) with obesity with or without comorbid pathology (chronic coronary artery disease i.e. CAD) were explicated in the research. Material and Methods. 126 patients with MS were examined. MS without chronic CAD was diagnosed in 82 patients and MS with chronic CAD was diagnosed in 44 patients. Levels of lipid spectrum, cortisol, prolactin, thyroid-stimulating hormone (TSH), free thyroxinе (fT4), glycosylated hemoglobin (HbAlc), and glucose were determined in all patients. Ultrasonography of the heart was taken into account. Results and Discussion. Increased levels of cortisol, TSH and prolactin (only in women) were observed in patients with MS without chronic CAD. Normal levels of cortisol and prolactin were observed in the patients with MS and chronic CAD simultaneously with increase of TSH levels in men and women the fT4 level was within normal limits. Changes in given parameters were accompanied by increase in total cholesterol (TCH), triglycerides (TG), low-density lipoprotein cholesterol (LDL CH) and very low-density lipoprotein cholesterol (VLDL CH) and decrease in high-density lipoprotein cholesterol (HDL CH) in patients with MS and chronic CAD regardless of gender, whereas only TG and VLDL CH were increased in patients with MS with obesity without chronic CAD. Interventricular septal thickness(IVST), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic size (LVEDS) as well as left atrium anteroposterior dimension (LA) increased in men and women with comorbid pathology, whereas only IVST and LA were increased in MS. Increased prolactin and TSH in women in contrast to men in MS with obesity have been established. High levels of TSH were recorded in the presence of combined pathology regardless of gender. Conclusion. Thus, diagnostic features of MS with obesity without chronic CAD are characterized by hormonal abnormalities in women, in contrast to men, whereas endocrine changes are not gender-specific in the presence of comorbid pathology.R.Ya. DutkaN.V. ChmyrDanylo Halytsky Lviv National Medical Universityarticlemetabolic syndrome, obesity, prolactin, thyroid-stimulating hormoneMedicine (General)R5-920ENUKActa Medica Leopoliensia, Vol 23, Iss 3, Pp 10-15 (2017)
institution	DOAJ
collection	DOAJ
language	EN UK
topic	metabolic syndrome, obesity, prolactin, thyroid-stimulating hormone Medicine (General) R5-920
spellingShingle	metabolic syndrome, obesity, prolactin, thyroid-stimulating hormone Medicine (General) R5-920 R.Ya. Dutka N.V. Chmyr Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
description	Aim. The differences between metabolic syndrome (MS) with obesity with or without comorbid pathology (chronic coronary artery disease i.e. CAD) were explicated in the research. Material and Methods. 126 patients with MS were examined. MS without chronic CAD was diagnosed in 82 patients and MS with chronic CAD was diagnosed in 44 patients. Levels of lipid spectrum, cortisol, prolactin, thyroid-stimulating hormone (TSH), free thyroxinе (fT4), glycosylated hemoglobin (HbAlc), and glucose were determined in all patients. Ultrasonography of the heart was taken into account. Results and Discussion. Increased levels of cortisol, TSH and prolactin (only in women) were observed in patients with MS without chronic CAD. Normal levels of cortisol and prolactin were observed in the patients with MS and chronic CAD simultaneously with increase of TSH levels in men and women the fT4 level was within normal limits. Changes in given parameters were accompanied by increase in total cholesterol (TCH), triglycerides (TG), low-density lipoprotein cholesterol (LDL CH) and very low-density lipoprotein cholesterol (VLDL CH) and decrease in high-density lipoprotein cholesterol (HDL CH) in patients with MS and chronic CAD regardless of gender, whereas only TG and VLDL CH were increased in patients with MS with obesity without chronic CAD. Interventricular septal thickness(IVST), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic size (LVEDS) as well as left atrium anteroposterior dimension (LA) increased in men and women with comorbid pathology, whereas only IVST and LA were increased in MS. Increased prolactin and TSH in women in contrast to men in MS with obesity have been established. High levels of TSH were recorded in the presence of combined pathology regardless of gender. Conclusion. Thus, diagnostic features of MS with obesity without chronic CAD are characterized by hormonal abnormalities in women, in contrast to men, whereas endocrine changes are not gender-specific in the presence of comorbid pathology.
format	article
author	R.Ya. Dutka N.V. Chmyr
author_facet	R.Ya. Dutka N.V. Chmyr
author_sort	R.Ya. Dutka
title	Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
title_short	Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
title_full	Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
title_fullStr	Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
title_full_unstemmed	Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
title_sort	differential diagnostic features of metabolic syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences
publisher	Danylo Halytsky Lviv National Medical University
publishDate	2017
url	https://doaj.org/article/b2531dbb6b654cf983a2155762d62d8b
work_keys_str_mv	AT ryadutka differentialdiagnosticfeaturesofmetabolicsyndromewithobesityinthepresenceorabsenceofchroniccoronaryarterydiseaseconsideringgenderdifferences AT nvchmyr differentialdiagnosticfeaturesofmetabolicsyndromewithobesityinthepresenceorabsenceofchroniccoronaryarterydiseaseconsideringgenderdifferences
_version_	1718439709906042880

Differential diagnostic features of Metabolic Syndrome with obesity in the presence or absence of chronic coronary artery disease considering gender differences

Ejemplares similares